These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9757850)

  • 1. Physician recommendations vs insurance coverage for growth hormone.
    Tesch LG
    JAMA; 1998 Sep 23-30; 280(12):1053; author reply 1053-4. PubMed ID: 9757850
    [No Abstract]   [Full Text] [Related]  

  • 2. Physician recommendations vs insurance coverage for growth hormone.
    Berman JI
    JAMA; 1998 Sep 23-30; 280(12):1052-3; author reply 1053-4. PubMed ID: 9757849
    [No Abstract]   [Full Text] [Related]  

  • 3. Physician recommendations vs insurance coverage for growth hormone.
    Yaes RJ
    JAMA; 1998 Sep 23-30; 280(12):1053; author reply 1053-4. PubMed ID: 9757851
    [No Abstract]   [Full Text] [Related]  

  • 4. The chasm: what can be done, and what should be done.
    Brown E
    Physician Exec; 1997 Feb; 23(2):39-41. PubMed ID: 10164976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone coverage policy and implementation: a four-year experience.
    Katz HP
    HMO Pract; 1997 Jun; 11(2):68-73. PubMed ID: 10168111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Growth hormone therapy in children. Attempt at a controlled extension of indications].
    Rappaport R
    Rev Prat; 1992 Oct; 42(15):1930-3. PubMed ID: 1485090
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA approves human growth hormone for wasting syndrome.
    AIDS Patient Care STDS; 1996 Dec; 10(6):379-80. PubMed ID: 11361571
    [No Abstract]   [Full Text] [Related]  

  • 8. [Growth hormone treatment in 1987].
    Wit JM; Steendijk R; Stoelinga GB; van den Brande JL
    Ned Tijdschr Geneeskd; 1987 Jan; 131(4):142-3. PubMed ID: 3821993
    [No Abstract]   [Full Text] [Related]  

  • 9. Expensive therapies in children: benefit versus cost of combined treatment of recombinant human growth hormone and gonadotropin-releasing hormone analogue in girls with poor height potential.
    Toumba M; Kokotsis V; Savva SC; Skordis N
    J Pediatr Endocrinol Metab; 2014 Mar; 27(3-4):311-6. PubMed ID: 24158419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human growth hormone. A case study in treatment priorities.
    Tauer CA
    Hastings Cent Rep; 1995; 25(3):S18-20. PubMed ID: 7649735
    [No Abstract]   [Full Text] [Related]  

  • 11. Growth hormone use in transitioning patients--clinician and payer concerns.
    LaFranchi S; MacGillivray MH; Fullerton P
    Am J Manag Care; 2000 Sep; 6(15 Suppl):S828-34. PubMed ID: 11184424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More on growth hormone therapy for otherwise normal short children.
    Schoen EJ
    J Pediatr; 1991 Aug; 119(2):341-2. PubMed ID: 1861233
    [No Abstract]   [Full Text] [Related]  

  • 13. Group asks NIH to stop growth hormone trials.
    Anderson C
    Nature; 1992 Jul; 358(6381):4. PubMed ID: 1614528
    [No Abstract]   [Full Text] [Related]  

  • 14. Human growth hormone approved for wasting.
    James JS
    AIDS Treat News; 1996 Sep; (No 254):1-4. PubMed ID: 11363817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rifkin wins battle over NIH growth trials.
    Watson T
    Nature; 1992 Aug; 358(6387):529. PubMed ID: 1501698
    [No Abstract]   [Full Text] [Related]  

  • 16. A national study of physician recommendations to initiate and discontinue growth hormone for short stature.
    Silvers JB; Marinova D; Mercer MB; Connors A; Cuttler L
    Pediatrics; 2010 Sep; 126(3):468-76. PubMed ID: 20805144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medi-Cal reimburses for growth hormone.
    AIDS Patient Care; 1995 Dec; 9(6):307. PubMed ID: 11361448
    [No Abstract]   [Full Text] [Related]  

  • 18. Growth hormone therapy-established uses in short children.
    Schwenk WF
    Acta Paediatr Suppl; 2006 Jul; 95(452):6-8. PubMed ID: 16801157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult height predictions for Constitutional Growth Delay, growth hormone treatment for idiopathic short stature and the FDA: are they related?
    Rapaport R
    Horm Res; 2006; 65(4):197-9. PubMed ID: 16549933
    [No Abstract]   [Full Text] [Related]  

  • 20. Developments in idiopathic short stature: cost versus allocation of resources.
    Durand-Zaleski I
    Horm Res Paediatr; 2011; 76 Suppl 3():33-5. PubMed ID: 21912159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.